These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29923000)

  • 1. Effects of Thermoextracts of Brucella S and L Forms on Lipid Peroxidation and Antioxidant Defense in Organs of Laboratory Animals.
    Dubrovina VI; Balakhonov SV; Yurieva OV; Starovoitova TP; Barannikova NL; Tokareva LE; Pyatidesyatnikova AB; Yastremskaya KY; Shkaruba TT
    Bull Exp Biol Med; 2018 Jun; 165(2):239-242. PubMed ID: 29923000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
    Lalsiamthara J; Lee JH
    Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the immunobiological properties of live brucellosis vaccines.
    Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
    Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brucella L-forms, their revertants and initial cultures].
    Taran IF; Tsybin BP; Krylova AA; Abolina TA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):39-43. PubMed ID: 6794254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against Brucella with killed vaccines. II. Immunizing activity of killed Brucella vaccines in guinea pigs.
    Rasooly G; Olitzki AL; Sulitzeanu D
    Isr J Med Sci; 1967; 3(6):814-21. PubMed ID: 4968077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of the reaction of the macrophage lysosomal apparatus in guinea pigs immunized with a live and a killed Br. abortus culture].
    Shuvalov LP; Korn MIa; Gavril'chak AV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):26-9. PubMed ID: 821275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal immunizing doses of vaccinal strains of Brucella].
    Shumilov KV
    Veterinariia; 1979 Aug; (8):31-4. PubMed ID: 113924
    [No Abstract]   [Full Text] [Related]  

  • 9. On the pathogenicity of nonstable Brucella L-forms and their revertants.
    Grekova NA; Tolmacheva TA; Vershilova PA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):129-34. PubMed ID: 119809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [COMPARATIVE STUDY OF THE VACCINAL PROCESS AND THE INTENSITY OF IMMUNITY IN GUINEA PIGS VACCINATED WITH BR. ABORTUS 19 AND 104-M].
    TARAN IF; NELIAPIN NM; POLIAKOVA AM; LUNINA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Feb; 41():53-60. PubMed ID: 14178350
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between macrophage migration inhibition and immunity to Brucella abortus in guinea-pigs.
    Cameron CM; Van Rensburg JJ; Engelbrecht MM
    Onderstepoort J Vet Res; 1976 Dec; 43(4):175-84. PubMed ID: 828715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistence of brucellosis L cultures in the body of an experimental animal and the duration of immunity].
    Vershilova PA; Grekova NA; Tolmacheva TA
    Vestn Akad Med Nauk SSSR; 1985; (3):10-3. PubMed ID: 3922151
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental study on the protective antigen derived from the vaccine strain Brucella abortus BA-19.
    Milerová J
    Prog Immunobiol Stand; 1967; 3():269-74. PubMed ID: 4985512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Virulence of Brucella abortus species L forms for guinea pigs].
    Ostrovskaia NN; Tolmacheva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):146-7. PubMed ID: 4212877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the interaction of L-transformed Brucella with a culture of peritoneal macrophages].
    Shuvalov LP; Tolmacheva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):15-9. PubMed ID: 4212835
    [No Abstract]   [Full Text] [Related]  

  • 20. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.